Market Access
pharmaphorum podcast episode 115

The 2024 biopharma M&A landscape: An overview

It’s been a couple of months since pharma’s annual JP Morgan Chase Healthcare Conference, where the mood around pharma M&A this year was optimistic, albeit with a few caveats.

Market Access
scaling innovation
Sponsored

Scaling innovation across hospitals and nations

Creating healthcare interventions and technological solutions that work is hard enough. But when the goal is sustainable system-wide improvement, it’s the easy part.

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. Lilly says Foundayo safety confirmed in ACHIEVE-4 trial
  2. Trump names Erica Schwartz to fill leadership void at CDC
  3. OpenAI introduces GPT-Rosalind, its drug discovery AI
  4. Amazon launches its AI drug discovery platform
  5. Revolution rockets on strong pancreatic cancer data

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

Patients
Anatomical graphic concept of a liver in 3D

Rewriting the MASLD playbook

Effective care now requires identifying metabolic risks early and addressing the broader factors driving liver damage.

Patients
pharmaphorum podcast Episode 254, Thomas Goetz, Drug Story

Every drug is a story, with Thomas Goetz

Thomas Goetz, creator and host of the Drug Story podcast on recognising pharmaceutical medicine as the socially and morally complex market that it is.

more

R&D

more